PAPeter J. Apel

Peter J. Apel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peter J. Apel has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Provision of Video Education Instead of an In-person Visit for Pediatric Buckle Fractures: A Randomized Controlled Trial

    by Mosufa Zainab, Mehmet E. Bs Kilinc, Devon R. Pekas, Youngjae Lee, Andrea A. Mshs Yu-Shan, Julie A. Zielinski, Peter J. Apel

    Introduction: Pediatric buckle fractures are common. These are often referred to as orthopaedic surgery offices, despite evidence that specialty evaluation is unnecessary. Here, we sought to determine if the provision of an educational video instead of an in-person visit with an orthopaedic provider would be non-inferior for patient-reported outcomes and demonstrate improvement in other outcomes, such as patient, caregiver, and provider time spent on caring for this injury. Methods: This was a single-center, prospective, randomized controlled, non-inferiority trial of 41 patients with distal radius buckle fractures. The video group was emailed a 1.5-minute educational video and did not have any in-person visits with an orthopaedic provider. The in-person group had a standard in-person visit. Patients were followed over 6 weeks. A non-inferiority analysis was performed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Short Form v2.0—Upper Extremity 8a. Other outcome measures were collected for satisfaction, time spent on healthcare activities, missed time from work/school, and provider time spent delivering care. Results: Compared with the in-person group, the video group demonstrated a non-inferior PROMIS score improvement from baseline to 6 weeks post-injury. Both groups were overall satisfied with their care, with no statistically significant difference. Patients and caregivers in the video group spent significantly less mean±SD time on healthcare activities aside from learning (video: 59.8±54.1 min vs. in-person: 144.1±95.2 min; P =0.002), had less time missed from work (video: 8.5±27.4 min vs. in-person: 137.1±246.1 min; P =0.006), and less time missed from school (video: 95.1±209.3 min vs. in-person 191.4±259.2 min; P =0.037). In addition, the provider spent significantly less time delivering care for patients in the video group (video: 0.0±0.0 min vs. in-person: 33.7±17.9 min). Conclusions: For patients with distal radius buckle fractures, video-based education should be considered as an alternative to an in-person orthopaedic visit. Level of Evidence: Therapeutic Level I.


  • Survivorship and Patient Satisfaction With Stablyx Implant for Thumb Carpometacarpal Arthroplasty

    by Camden O. Novikova, Kelsey M. Gray, Nicholas J. Peterman, Miles C. Farlow, Micheala I. McCarthy, Anthony E. Capito, Peter J. Apel

    Background: Many surgical techniques and devices are available to address thumb carpometacarpal (CMC) joint arthritis. To date, limited evidence exists regarding patient satisfaction, patient-reported outcomes, and revision-free survivorship of the Stablyx implant. We sought to examine these metrics for these implants against conventional CMC arthroplasty techniques. Methods: Six hundred and thirty-one patients who underwent CMC arthroplasty were identified at our institution. Patients were contacted to obtain patient satisfaction scores, Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) scores, and potential revision dates. Retrospective chart review was then performed on all 287 respondents. Respondents were placed into cohorts based on the arthroplasty surgical technique: (1) Stablyx (n = 53); (2) ligament reconstruction and tendon interposition (LRTI) with the flexor carpi radialis (n = 90); (3) abductor pollicis longus (APL) suspensionplasty (n = 71); and (4) TightRope suspensionplasty (n = 73). Minimum follow-up was 6 months with an average follow-up of 3.6 ± 2.2 years for the Stablyx cohort and 5.3 ± 2.8 years for all other CMC arthroplasty techniques (AOCAT). Patient demographics, including age, sex, smoking status, Eaton score, and operating surgeon, were also examined. Results: Through multivariable modeling, higher revision rates were observed in patients who received Stablyx than those who underwent LRTI (control), APL suspensionplasty, or TightRope suspensionplasty. Dissatisfaction was greater in the Stablyx cohort (35%) than the AOCAT cohort (6.8%). No difference in QuickDASH scores were observed between groups. Conclusions: Higher revision rates and lower patient satisfaction scores were seen in patients who underwent Stablyx CMC hemiarthroplasty compared with other arthroplasty techniques.


  • The Role of the Obturator Nerve—Acute Nerve Grafting After Resection of a Plexiform Obturator Nerve Schwannoma

    by Peter J. Apel, Shannon D. Armbuster, Patrick S. Rush, Jasraj S. Raghuwanshi

    Case: A 45 year-old woman presented with an obturator nerve schwannoma (ONS), which was originally suspected to be a gynecologic malignancy. After thorough workup, the mass and obturator nerve were resected en bloc, and sural nerve grafting was performed. The patient had minimal deficits with return to baseline activities by 7 weeks postoperatively. Conclusion: We guide the reader through the challenging diagnosis of ONS, which may mimic many other intrapelvic masses. The treatment decision of whether to acutely reconstruct the obturator nerve is also discussed, along with implications and functional importance of the nerve in gait and hip motion.

  • Patient-Directed Care After Carpal Tunnel Release Using Video Integration and Digital Education After Operations (VIDEO Trial): A Randomized Controlled Trial

    by Randall G. Bissette, Jadon H. Beck, Camden O. Novikova, Youngjae Lee, Nicholas J. Peterman, Cesar J. Bravo, Peter J. Apel

    Background: Carpal tunnel release (CTR) is a successful procedure with consistent outcomes. Routine in-person postoperative visits are of questionable value. It remains to be seen whether video education and patient-directed care after CTR can replace in-person postoperative visits. Methods: Eighty-three patients undergoing CTR were analyzed in a prospective, randomized, controlled trial comparing in-person follow-up to an experimental program with Video Integration and Digital Education after Operations (VIDEO). Patients underwent open, wide-awake, local-anesthetic, no-tourniquet CTR in-office. Those in the control (in-person) group returned for week 2 and week 6 postoperative in-person visits. Those in the experimental (VIDEO) group did not have scheduled in-person visits but were provided 3 educational videos (1-2 minutes). All patients had access to electronic messaging and could call or come in-person for unplanned visits. The Patient-Reported Outcome Measurement Information System Upper Extremity Computer Adaptive Test 2.0 (PROMIS UE CAT v2.0) was assessed for noninferiority. Patient satisfaction, time off work, time traveling, complications, unplanned visits, phone calls, and messages were assessed. Results: Compared to the in-person group, the VIDEO group demonstrated noninferior PROMIS UE CAT 2.0 score improvements. Patients in both groups were generally satisfied with care, while some expressed higher or lower satisfaction than others. Patients in the VIDEO group missed less time from work and spent less time traveling. There was no difference in complications, unplanned visits, phone calls, or patient messages between groups. Conclusions: For select patients, video education and patient-directed care should be considered as an alternative to in-person follow-up after CTR.

  • The Role of Noninferiority Studies in Orthopaedic Surgery: Determining Whether Outcomes Are the Same, No Worse, or Simply Not Different

    by W. Garret Burks, Youngjae Lee, Kelly Gordon, Alison N. Tegge, Peter J. Apel

    ➢ With any study, readers should be cautious and critical when the conclusion is that “these treatments are the same.” ➢ If only superiority testing was performed, failing to find a difference does not mean that the treatments are the same, even when the study was adequately powered. ➢ Noninferiority analysis is the correct method to compare treatments that researchers and clinicians think may be “the same” for the primary outcome. ➢ The most important aspect of a noninferiority analysis is the selection of the noninferiority margin, which is the minimum difference between groups that would be considered meaningful. ➢ To perform noninferiority testing, the difference in an outcome measure of interest between experimental and control groups must be examined with respect to the noninferiority margin of the same outcome measure. Assuming that a greater value indicates improvement in an outcome measure, if the lower bound of a 95% confidence interval of a difference in means based on a 1-sided test is greater than the noninferiority margin, then the experimental treatment can be considered noninferior to the control.


  • Open Access

    Lower Extremity Targeted Muscle Reinnervation for Mononeuropathy in Nonamputation Patients: Techniques and Tips

    by Kelly A. Dpm Kugach, Camden Bs Novikova, Rachel Schwartz, Anthony Capito, Peter J. Apel

    Summary: Painful mononeuropathies in nonamputation patients are prevalent and have historically been difficult to treat. Targeted muscle reinnervation (TMR) is known to reduce pain in amputation patients and those with neuroma formation. However, there is little known about TMR in nonamputation patients, and there is a lack of described techniques for performing TMR in lower extremity nonamputation patients. This article presents techniques for TMR in the lower extremity for nonamputation patients using cadaver dissection and surgical videos. The authors describe tips and tricks for performing these procedures, and the rationale for selecting recipient muscles for TMR in the lower extremity in nonamputation patients is reviewed.

  • Factors That Influence Returning to Driving Following Primary Total Knee Arthroplasty

    by Devon R. Pekas, Miguel Perez, Andrea A. Yu-Shan, Cody Bailey, Nicholas Peterman, Mehmet E. Kilinc, W. Garret Burks, Joseph T. Moskal, Benjamin R. Coobs, Peter J. Apel

    Background: It is unclear when a patient can return to driving after total knee arthroplasty (TKA). Currently, most surgeons simply restrict all patients from driving for 4 to 6 weeks after TKA despite variability in patient age, general health, and physical capabilities. The primary objective of this study was to create novel clinical prediction calculators to estimate the return-to-driving time following primary TKA. Methods: In this study, 167 patients who were undergoing a primary TKA were prospectively enrolled. Subjects received text message surveys every third day postoperatively to determine when they returned to driving. Subjects completed 8 physical performance maneuvers at their 2, 6, and 12-week postoperative clinical appointments. Additionally, subjects completed return-to-driving surveys and a structured interview. Data on demographic characteristics, operative factors, patient-reported outcomes, and patient factors were collected. Cox proportional hazard and parametric survival models were utilized to create 2 novel calculators for predicting return-to-driving time. Results: There were 156 patients (mean age, 67.7 years [range, 39 to 83 years]) who completed the study. The median return-to-driving time was 18 days (interquartile range [IQR], 12 to 27 days). Univariate analysis demonstrated that male patients returned to driving sooner (18 days) than female patients (25.3 days) (p < 0.001) and that patients who underwent left-sided surgery returned to driving sooner (20.1 days) than patients who underwent right-sided surgery (24.4 days) (p = 0.021). For preoperative factors, age, sex, laterality, and preoperative Knee injury and Osteoarthritis Outcome Score (KOOS) had an effect on return-to-driving time and therefore were included in the novel preoperative clinical prediction calculator. For postoperative factors, age, sex, laterality, preoperative KOOS, and 6 metrics from the physical performance maneuvers had an effect on return-to-driving time and therefore were included in the novel postoperative physical performance-based instrument. Conclusions: Overall, patients undergoing primary TKA returned to driving considerably earlier than previously reported. Patient-related factors and postoperative physical performance significantly affect return-to-driving time. Using the novel preoperative clinical prediction tool, individual patients can be advised when to expect to return to driving. After surgery, the novel postoperative physical performance-based instrument can inform patients when they may be ready to return to driving. Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Impact of the COVID-19 Pandemic on Buckle Fracture Treatment

    by Mehmet E. Kilinc, Evan P. Sandefur, Mosufa Zainab, Nicholas J. Peterman, Andrea A. Yu-Shan, Peter J. Apel


  • Modifications to the Geriatric Nutritional Risk Index Predicts Complications After Total Joint Arthroplasty

    by Brian K. Hansen, Devon R. Pekas, Garret W. Burks, Evan P. Sandefur, Peter J. Apel, Murillo Adrados


  • Open Access

    Environmental Impact of Overtreatment of Distal Radius Buckle Fractures

    by Mosufa Zainab, Evan P. Sandefur, Nicholas J. Peterman, Mehmet E. Kilinc, Andrea A. Yu-Shan, Peter J. Apel

    Introduction: Pediatric buckle fractures are common. Current literature supports a single provider visit with education and removable wrist brace/bandage, without additional follow-up visits. Potential overtreatment through casting and follow-up visits may impose a substantial environmental burden through waste generated from casts and vehicular CO2 emission. This study seeks to estimate the national environmental impact of buckle fracture overtreatment through geospatial analysis extrapolated from a review of buckle fracture treatment at our institution. Methods: A retrospective chart review was performed to determine incidence and treatment of buckle fractures at our institution between 2018 and 2022. All radiographs were reviewed to confirm appropriateness for inclusion. Data were collected for treatment, follow-up frequency, cast utilization, and patient home ZIP code. Buckle fracture incidence was computed using the total pediatric population served by our institution, derived from United States (US) Census data. Treatment was assumed to occur at the office of the nearest orthopedic surgeon, identified through the National Provider Identifier Registry. For cast waste estimation, we collected and weighed discarded short-arm casts from our institution and used the number of patients treated in a cast to estimate total waste. CO2 emissions were estimated to be 411 g of CO2 per mile, and mileage was calculated for round-trip distance to the nearest orthopedic surgeon and multiplied by the estimated number of unnecessary visits. Travel for the initial visit was not considered overtreatment and was not included. Results: Annually, the United States sees an estimated 66,495 buckle fractures, with 62.5% overtreated with casting. The average short-arm cast weighed 0.498 lbs ± 0.133. When additional visits occurred, there were an average of 1.2 additional visits. Each year, overtreatment of pediatric buckle fractures in the United States generates an estimated 9.4 tons of cast waste and 405.4 tons of CO2. Conclusion: Overtreatment of buckle fractures has a significant measurable environmental impact.